Medical Delivery Research Articles

Microsponge: A Review

Microsponge are little spherical molecules with a broad porous surface that resemble sponges. The use of microsponges is a unique medication delivery method that has several benefits. For a range of illnesses, the Microsponges drug delivery system is utilized to improve the effectiveness of oral, parenteral, or topical medicine administration. A novel approach of managing drug release and administering medication to specific locations is microsponge technology. The efficient and novel way that microsponge medicine administration advances properties, boosts item stability, and improves security can all contribute to the effectiveness of topically dynamic operators. In an effective and creative way, it can boost the efficiency of topically active medications while improving safety, product stability, and aesthetic qualities. Recently, microsponges, which are typically used topically, have also been employed for oral delivery. Microsponge Systems may suspend or trap a wide range of substances. They can also be integrated into a product that is made to resemble a gel, cream, liquid, or powder. Microsponge Systems are built on atomic, polymer-based microspheres. In topical medication solutions, microsponge technology has been employed to provide controlled release of active drug into the skin, therefore decreasing systemic exposure and local cutaneous responses to active pharmaceuticals. We will talk about microsponge's characteristics, benefits, and drawbacks as well as the drug release mechanism, formulation techniques, and assessment in this review paper. Keywords: Microsponge, NDDS, Novel drug delivery system, MDS

Study on Synthesis and Characterization of Metal Nanoparticles for Biomedical Applications

In this research paper, I have thoroughly described about the topic “Study on Synthesis and Characterization of Metal Nanoparticles for Biomedical Applications.” Metal nanoparticles have emerged as promising candidates for a myriad of biomedical applications due to their unique physicochemical properties, offering a wide array of opportunities for innovation in healthcare. This abstract discusses metal nanoparticle creation, characterization, and biomedical applications. Chemical reduction, green synthesis, physical deposition, and biological methods allow fine nanoparticle size, shape, and composition control for biomedical applications. TEM, DLS, XRD, UV-Vis, FTIR, SEM, and TGA reveal metal nanoparticles' structural, chemical, and optical properties. Metal nanoparticles are used in medication delivery, imaging contrast, targeted therapy, and diagnostics. Their small size, large surface area-to-volume ratio, and tunable optical properties make them suitable for drug delivery, where they can encapsulate and release therapeutic substances at precise body regions. Metal nanoparticles also improve illness identification and monitoring in MRI, CT, and fluorescence imaging by acting as contrast agents. They provide innovative cancer and microbial infection treatments due to their photothermal and antibacterial characteristics. Metal nanoparticles also find utility in biosensing applications, facilitating the detection of biomolecules and disease biomarkers with high sensitivity and specificity. Overall, the synthesis and characterization of metal nanoparticles represent a vibrant area of research with significant implications for advancing healthcare technologies, offering versatile platforms for addressing key challenges in diagnostics, therapeutics, and imaging in biomedicine.

Intranasal Delivery of Medications for the Treatment of Neurologic Conditions: A Pharmacology Update.

INTRODUCTION: Nurses have a central role in educating patients and families about treatment options and how to integrate them into action plans for neurologic conditions. In recent years, a growing number of intranasal formulations have become available as rescue therapy for neurologic conditions or symptoms including migraine, opioid overdose, and seizures. Rescue therapies do not replace maintenance medications or emergency care but are designed to enable rapid treatment of urgent or disabling conditions in community settings. Yet, discussion of rescue therapies for neurologic conditions remains limited in nursing literature. CONTENT: Intranasal formulations are specifically formulated for delivery and absorption in the nose and have several characteristics that are well suited as rescue therapies for neurologic conditions. Intranasal formulations include triptans for migraine, naloxone and nalmefene for opioid overdose, and benzodiazepines for seizure clusters in patients with epilepsy. Therapeutic attributes discussed here include ease of use in community settings by nonmedical professionals, relatively rapid onset of action, and favorable safety profile and patient experience. This information is critical for nurses to make informed decisions about rescue therapy options, incorporate these into plans of care, and educate patients, care partners, and other healthcare providers. CONCLUSION: Rescue therapies are increasingly important in the care of people with neurologic conditions. Various formulations are available and continue to evolve, offering easy and quick ways for nurses, patients, and nonmedical care partners to administer critical rescue medications. For nurses overseeing medication management, the attributes of intranasal rescue therapies should be considered in the context of providing patients with the right care at the right time.

A histological and immunohistochemical investigation to assess the therapeutic role of metformin nanoemulsion against metformin in a diabetic retinopathy model

ABSTRACT The fundamental concept of diabetes research is the restoration of normal glycemic status. Nowadays, nanoemulsion medication delivery technologies provide effective approaches to the second type of diabetes mellitus care. This study aimed to investigate the potential of metformin nanoemulsion (MTF-NE) in treating streptozotocin (STZ)-induced diabetic retinopathy in rats. Histopathological examinations, including hematoxylin and eosin, anti-F-actin, anti-CD57, and anti-S100 immunostains, were performed after 8 weeks. Many alterations in the STZ group as slight disorganization of retinal layers, loss of some photoreceptor processes, and focal widening of intercellular spaces between small darkly stained nuclear cells in inner and outer nuclear layers, focal areas of disruption of outer plexiform layer, pyknotic nuclei of ganglion cells, and dilated congested blood capillaries with vascular leakage in the ganglion cell layer, decreased F-actin, increased CD75 and S100 immunohistochemical expression. Rats treated with metformin nanoemulsion have substantial improvements in retinal organization, histopathology, and immunohistochemical markers compared to those treated with metformin. The study suggests that metformin nanoemulsion holds promise for alleviating diabetic retinopathy in rats on a histological and immunohistochemical basis.

Secure System with Security Protocol for Interactions in Healthcare Internet of Things

The Internet of Things is a network of connected devices that can communicate and share data over the Internet. These devices often have sensors that collect data for various purposes, such as usage statistics, data processing, or performing specific actions based on the collected data. Also, medical Internet of Things devices are crucial in monitoring critical functions, measuring blood glucose levels, indicating when patients require medicine, and ensuring timely medication delivery. Communication in the Internet of Things is demanding, requiring diverse protocols that address communication security concerns. These protocols must be robust and secure, considering technical factors such as the network’s objective, energy requirements, and the nature of the communication because they can be exploited. This paper proposes an innovative system with a security protocol that supports and improves communication security in modern Internet of Things networks. The protocol aims to enhance communication safety between interconnected devices for information exchange in medicine or healthcare, ensuring the confidentiality and integrity of sent data and devices. The proposed protocol, tested through formal and automated verification, meets all security goals, including identity verification, anonymity protection, and access revokement. It also protects against Man-in-the-middle, modification, replay, and impersonation attacks.

Towards the Improvement of Patient Experience Evaluation Items for Patient-Centered Care in Head and Neck Cancer: A Qualitative Comparative Study.

Owing to long-term treatment, frequent consultations, and complications, the evaluation of patients with head and neck cancer (HNC) must be improved. This study explored an opportunity for improving patient experience (PE) evaluation of patients with HNC to achieve a patient-centered, integrative evaluation model based on patient needs. The study comprised four phases: (1) a systematic literature review of PE factors for patient quality of life (QoL) and establishment of PE factor categories as a framework, (2) a review of current cancer or HNC PE evaluation tools, (3) identification of potential PE evaluation items based on patient needs by conducting user research, and (4) suggestion of integrative HNC PE evaluation items through expert validation. As a result, the 39 potential items were initially identified from the literature review and user research. After conducting two survey rounds with experts, 25 items were suggested as HNC PE evaluation items. These underscore the importance of highlighting the patient's participation, the medical staff's comprehensive information delivery, empathy, and collaborative communication, the hospital's support of communication channels, the medical environment for patient emotional support, the education program, and systematic patient satisfaction data management. PE evaluation items that consider the diverse perspectives of stakeholders involved in HNC treatment and factors of comprehensive PE will contribute to improving HNC patient-centered care (PCC).

The Applicability of Nanostructured Materials in Regenerating Soft and Bone Tissue in the Oral Cavity-A Review.

Two of the most exciting new technologies are biotechnology and nanotechnology. The science of nanostructures, or nanotechnology, is concerned with the development, testing, and use of structures and molecules with nanoscale dimensions ranging from 1 to 100 nm. The development of materials and tools with high specificity that interact directly at the subcellular level is what makes nanotechnology valuable in the medical sciences. At the cellular or tissue level, this might be converted into focused clinical applications with the greatest possible therapeutic benefits and the fewest possible side effects. The purpose of the present study was to review the literature and explore the applicability of the nanostructured materials in the process of the regeneration of the soft and hard tissues of the oral cavity. An electronic search of articles was conducted in several databases, such as PubMed, Embase, and Web of Science, to conduct this study, and the 183 articles that were discovered were chosen and examined, and only 22 articles met the inclusion criteria in this review. The findings of this study demonstrate that using nanoparticles can improve the mechanical properties, biocompatibility, and osteoinductivity of biomaterials. Most recently, breakthroughs in tissue engineering and nanotechnology have led to significant advancements in the design and production of bone graft substitutes and hold tremendous promise for the treatment of bone abnormalities. The creation of intelligent nanostructured materials is essential for various applications and therapies, as it allows for the precise and long-term delivery of medication, which yields better results.

A systematic review of collaborative robots for nurses: where are we now, and where is the evidence?

Introduction: Robots present an opportunity to enhance healthcare delivery. Rather than targeting complete automation and nurse replacement, collaborative robots, or "cobots", might be designed to allow nurses to focus on high-value caregiving. While many institutions are now investing in these platforms, there is little publicly available data on how cobots are being developed, implemented, and evaluated to determine if and how they support nursing practice in the real world. Methods: This systematic review investigates the current state of cobotic technologies designed to assist nurses in hospital settings, their intended applications, and impacts on nurses and patient care. A comprehensive database search identified 28 relevant peer-reviewed articles published since 2018 which involve real studies with robotic platforms in simulated or actual clinical contexts. Results: Few cobots were explicitly designed to reduce nursing workload through administrative or logistical assistance. Most included studies were designed as patient-centered rather than nurse-centered, but included assistance for tasks like medication delivery, vital monitoring, and social interaction. Most applications emerged from India, with limited evidence from the United States despite commercial availability of nurse-assistive cobots. Robots ranged from proof-of-concept to commercially deployed systems. Discussion: This review highlights the need for further published studies on cobotic development and evaluation. A larger body of evidence is needed to recognize current limitations and pragmatic opportunities to assist nurses and patients using state-of-the-art robotics. Human-centered design can assist in discovering the right opportunities for cobotic assistance. Committed research-practice partnerships and human-centered design are needed to guide the technical development of nurse-centered cobotic solutions.

Emerging Trends in Novel Drug Delivery Systems for the Effective Treatment of Oral Cancer

Background: The consumption of tobacco and alcohol has been correlated with the development of oral cancer, impacting various areas such as the mouth, lips, tongue, cheeks, and throat. This condition is marked by irregular cell proliferation involving intricate genetic and epigenetic alterations that drive tumorigenesis. Traditional treatments face limitations, necessitating a comprehensive multidisciplinary strategy. Novel Drug Delivery Systems [NDDS] offer groundbreaking therapeutic possibilities in addressing this complex health challenge. Objective: This review emphasizes the use of NDDS in the treatment of oral cancer Methods: The review entailed a comprehensive exploration of scientific databases and pertinent publications, encompassing studies conducted up to the current date sourced from PubMed, Science Direct, and Google Scholar Key. The search terms incorporated "oral cancer," "novel drug delivery system," "chemotherapy," "nanotechnology," and "conventional therapy." The chosen studies underwent meticulous assessment for methodological robustness and the importance of their findings. Results: NDDS serve an important role in targeted medication delivery by increasing drug bioavailability and reducing adverse effects. Addressing challenges such as low drug solubility, NDDS excels in sustained release methods, guaranteeing long-term therapeutic impact. Their versatility extends to the encapsulation of several anticancer drugs, giving a potential option for oral cancer treatment that is both efficacious and well-tolerated. This novel technique has the potential to transform treatment approaches, improving the efficacy and tolerability of oral cancer drugs. Conclusion: In oral cancer treatment, a spectrum of drug delivery systems is employed, encompassing conventional methods like oral and intravenous administration alongside innovative approaches such as vesicular systems, polymeric systems, and targeted strategies. Recent breakthroughs in oral cancer therapy, including immunotherapy [checkpoint inhibitors, CAR-T cell therapy] and gene therapy [siRNA, miRNA, CRISPR-Cas9], offer exciting prospects. These advancements hold the potential for enhanced therapeutic efficacy, minimized side effects, and personalized treatment options.

Current Aspects of Nanotechnology Based Healing Approaches for Diabetic Wounds

Abstract: Diabetic wounds represent a significant clinical challenge due to their chronic nature, slow healing rates, and susceptibility to infections, often leading to severe complications. Nanotechnology plays a transforming role in advancing diabetic wound repair therapies. The field of nanotechnology has shown great promise in the medical field in recent years, offering precise tools and materials at the nanoscale to address the complexities of diabetic wound management. The latest breakthroughs in nanomaterial design and fabrication showcase nanoparticles, nanofibers, and hydrogels tailored to enhance tissue regeneration, promote angiogenesis, and modulate the wound microenvironment. These engineered materials serve as versatile systems for the regulated release of cytokines and antimicrobial agents, offering a multifaceted approach to diabetic wound healing. Nanotechnology enables the growth of smart medication delivery technologies with accurate targeting and sustained delivery of medicinal substances right to the location of the wound. Prolonged injuries in hyperglycemic patients are particularly prone to infections, leading to prolonged healing times and increased morbidity. Some of the nanoscale antimicrobial agents, such as nanozyme-chitosan-derived hydrogel, silver nanoparticles, and antimicrobial peptides that exhibit potent bactericidal properties, reduce the risk of infections and associated complications. Nanosensors and advanced imaging techniques enable real-time monitoring of wound healing progress. These tools provide clinicians with valuable insights into tissue viability, inflammation levels, and treatment efficacy, facilitating timely adjustments to therapeutic regimens. This is an inclusive overview of the current state of nanotechnology for the treatment of diabetic wounds, offering insights into the promise and challenges of this innovative approach, by harnessing the unique properties of nanoscale materials and technologies.

Plant-derived Exosomes: Pioneering Breakthroughs in Therapeutics, Targeted Drug Delivery, and Regenerative Medicine.

Small extracellular vesicles called exosomes, which cells release, have drawn a lot of attention recently because of their ability to serve as therapeutic delivery systems for drugs and regenerative medicine applications. The investigation of plant-based exosomes as a cutting-edge platform for drug administration has emerged as an enticing research topic. A summary of the pharmaceutical feasibility of exosomes generated from plants and their uses in drug delivery along with regenerative medicine are the goals of this review study. Plant exosomes can be combined into nanoparticlebased medication delivery systems to increase their stability, targeting, and cargo delivery capabilities. By loading plant exosomes with therapeutic compounds and encapsulating them within nanoparticles, controlled release and targeted distribution to specific cells or tissues may be achieved. In gene therapy, plant exosomes can be modified to carry nucleic acids like plasmid DNA, siRNA, or miRNA. Effective gene delivery and therapeutic gene expression regulation can be accomplished by encasing nucleic acids in exosomes or surface-modifying exosomes to improve their interaction with target cells. In this review, we through the history and features of plant exosomes, examine how they differ from mammalian exosomes, and consider how they may be used for gene therapy, tissue regeneration, and targeted medication delivery. The difficulties and prospects for creating exosomebased plant medicines are also explored.

Pharmacy‐led optimization of transitions of care in patients with heart failure

AbstractIntroductionEffective transitional care for patients with heart failure is essential to ensure optimal utilization of guideline‐directed medical therapy. Clinical pharmacists and specially trained pharmacy technicians have unique skillsets that enable them to improve care transitions.ObjectivesTo evaluate the implementation of a comprehensive pharmacy transitions of care program in an acute heart failure population.MethodsA retrospective, single center, single‐arm study evaluating pharmacy‐delivered transitions of care services (admission and discharge medication reconciliation, medication cost assessment, medication counseling, bedside delivery of discharge medications, and post‐discharge phone calls) for patients discharged from the heart failure service. The primary outcome was the completion rate of transitions of care services. Secondary outcomes included the medication intervention rate and types of interventions made, medication classes assessed for cost, discharge medication prescription captured, and 30‐day all‐cause readmissions.ResultsFive hundred and ninety‐five patients were eligible for the transitions of care program. Admission and discharge medication reconciliations were completed in 68.1% and 92.1% of patients, respectively. Medication cost assessments were completed for 39.8% of patients. Heart failure medication counseling prior to discharge was completed for 83.9% of patients. Discharge prescription capture rate was 56.5% and bedside prescription delivery was provided for 27.8% of patients. The discharge medication reconciliation intervention rate was 37.4%, with the most common intervention being dose adjustment. Post‐discharge outreach was conducted for 229 patients, with education provided for 69.4% and an intervention rate of 43.7%. The 30‐day all‐cause readmission rate was lower for patients on the heart failure service compared with the institution (10.1% vs 16.5%).ConclusionHigh rates of completion and utilization were identified after the implementation of a comprehensive pharmacy transitions of care program. Utilization of clinical pharmacists and pharmacy technicians during transitions of care improved medication access, patient education, and reduced medication‐related problems.

Hyaluronic acid-poly(glyceryl)10-stearate nanoemulsion for co-delivery of fish oil and resveratrol: Enhancing bioaccessibility and antioxidant potency

Hyaluronic acid (HA), an endogenous polysaccharide comprising alternating D-glucuronic acid and N-acetylglucosamine units, is renowned for its high hydrophilicity, biocompatibility, and biodegradability. These attributes have rendered HA invaluable across medical and drug delivery fields. HA can be altered through physical, chemical, or enzymatic methods to improve the properties of the modified substances. In this work, we synthesized a derivative via the esterification of HA with poly(glyceryl)10-stearate (PG10-C18), designated as HA-PG10-C18. This novel derivative was employed to fabricate a nano co-delivery system (HA-PG10-C18@Res-NE) for fish oil and resveratrol (Res), aiming to enhance their stability and bioaccessibility. An exhaustive investigation of HA-PG10-C18@Res-NE revealed that the HA-modified system displayed superior physicochemical stability, notably in withstanding oxidation and neutralizing free radicals. Moreover, in vitro simulated digestion underscored the system's enhanced bioaccessibility of Res and more efficient release of free fatty acids. These outcomes underscore the strategic advantage of HA in modifying PG10-C18 for nanoemulsion formulation. Consequently, HA-PG10-C18 stands as a promising emulsifier for encapsulating lipophilic bioactives in functional foods, nutraceuticals, and pharmaceuticals.

Cold Chain Logistic for Pharmaceuticals Products

This research paper explores the important position of cold chain logistics inside the pharmaceutical quarter, focusing on the precise challenges and possibilities inside this area. The look at employs a group-primarily based move-sectional method, making use of each quantitative and qualitative facts to assess the performance of cold chain management for temperature-sensitive prescribed drugs. It highlights the fast improvement of bloodless chain logistics in China, driven via national rules, yet underscores the persistent challenges, along with the excessive value of pharmaceutical cold chain logistics, the need for technological improvements, and the scarcity of professional experts inside the field. The paper also addresses the imperfections within the regulatory machine governing pharmaceutical cold chain logistics, emphasizing the importance of setting up a standardized and transparent regulatory framework to ensure the safety and efficacy of pharmaceutical products at some point of their lifecycle. Through a complete evaluation of the current panorama and proposed optimization techniques, the research goals to make contributions to the enhancement of pharmaceutical bloodless chain logistics, selling the safe and green delivery of critical medications and vaccines. KEYWORDS: Research Paper, Pharmaceutical Cold Chain, Cold Chain Logistics, Optimization of Pharmaceutical Cold Chain, Logistics in Pharmaceutical Cold Chain Logistics, Cost of Pharmaceutical Cold Chain Logistics

Stimuli-responsive Biomaterials for Tissue Engineering Applications.

The use of ''smart materials,'' or ''stimulus responsive'' materials, has proven useful in a variety of fields, including tissue engineering and medication delivery. Many factors, including temperature, pH, redox state, light, and magnetic fields, are being studied for their potential to affect a material's properties, interactions, structure, and/or dimensions. New tissue engineering and drug delivery methods are made possible by the ability of living systems to respond to both external stimuli and their own internal signals) for example, materials composed of stimuliresponsive polymers that self assemble or undergo phase transitions or morphology transformation. The researcher examines the potential of smart materials as controlled drug release vehicles in tissue engineering, aiming to enable the localized regeneration of injured tissue by delivering precisely dosed drugs at precisely timed intervals.

Home Medication Delivery: Measuring Med Compliance in Pediatrics with Sickle Cell Disease

Home Medication Delivery: Measuring Med Compliance in Pediatrics with Sickle Cell Disease

A Brief Insight into Nanotherapeutic Approaches in the Management of Analgesia

Background: Growing public awareness of chronic pain resulting from illness and injury has prompted pharmaceutical researchers and drug corporations to create better, more targeted painkillers. For effective pain management, prolonged analgesic medication delivery at the intended areas continues to be a major problem such as addiction, tolerance and other serious side effects, which can prolong suffering and decrease painkiller effectiveness. Objective: The present paper focuses on review of current advances in the field of pain treatment by different nanoparticles formulations of various drugs, by enhancing their pharmacokinetic factors and diminishing associated adverse effects. Results: According to literature survey, usage of nano-carriers enables the delivery of these drugs to target locations with less systemic toxicity. Nanotechnology for varied therapeutic purposes, different analgesics have been loaded onto different nano carriers, including those that are natural, synthetic, and polymeric and proven to be beneficial in pain management. Conclusion: Overall, new nano based preparations and new ways to utilize existing medications in a variety of circumstances is a multimodal approach to pain relief, have resulted in recent advancements in the pharmacological management of pain.

Polymeric nanotheranostics for solid tumor management: Recent developments and global regulatory landscape

AbstractPolymeric nanotheranostics have emerged as promising vehicles for diagnosis‐cum‐targeted therapy in solid tumors, offering precise delivery of therapeutic agents at the site of solid tumors and minimizing systemic side effects. This article summarizes the latest developments in using polymeric nanoparticles for specific treatment strategies in solid tumors. It explores the various methods these nanoparticles utilize for targeted medication delivery. This includes passive targeting through the amplified permeability and retention effect, active targeting via interactions between ligands and receptors, and stimuli‐responsive release mechanisms such as pH, temperature, and enzymatic triggers. Furthermore, we highlight recent developments in stimuli‐responsive polymeric nanoparticles, which enable controlled drug release in response to specific cues in the tumor microenvironment, thus enhancing therapeutic efficacy. Also, we focus on the theranostic polymeric nanoparticles, which are used for diagnosing and treating solid tumors. We discuss critical regulatory considerations and the regulatory bodies of different countries that regulate nanomedicines' safety, efficacy, quality, and manufacturing processes. Overall, this review provides insights into the latest innovations in polymeric nanoparticles for targeted therapy in solid tumors, elucidating their mechanisms of action, stimuli‐responsive properties, and regulatory pathways, which collectively contribute to developing effective and safe nanomedicines for cancer treatment.

Smart Autonomous Nurse Assistant Robot (SANAR)

Abstract: In the evolving landscape of healthcare, the integration of innovative technologies has become paramount to enhance efficiency, accessibility, and usability across all sectors, particularly in the medical industry. This project proposes the development of a Smart Autonomous Nurse Assistant Robot (SANAR) aimed at revolutionizing medical care delivery, especially during emergencies and pandemics like Covid-19. SANAR utilizes cutting-edge technology to streamline disease diagnosis, monitor patient health in real-time, and facilitate drug delivery. The core of SANAR's functionality lies in its utilization of a health tracker system-based IoT platform, which continuously analyzes vital patient data, including oxygen levels, pulse rate, and temperature. Through simple text commands and a timer-based medicine scheduler, SANAR ensures timely medication administration, leveraging a cloud server for seamless data access and management with utmost security. Equipped with advanced sensors such as oximeter, heartbeat, ultrasonic sensors, and a voice module, SANAR leverages Internet of Things (IoT) technology to enable data storage and retrieval over HTTP and MQTT protocols, facilitating connectivity and scalability. The primary goal of this project is to democratize smart automation in healthcare, making it accessible and affordable to all segments of society, ultimately empowering medical staff to deliver efficient and effective care.

Review of Oral Tablet

Abstract: Oral drug delivery is noninvasive, has a high rate of patient compliance, is easy to handle, and doesn't require any special sterile settings, it is the most popular method of administration. Nevertheless, a number of physical, biological, and pharmacological obstacles that certain medications must overcome in order to be absorbed into the systemic circulation reduce their therapeutic efficiency. The use of nanocarriers to deliver drugs orally has proven to be an effective solution to the aforementioned problems and is being explored as a potential replacement for oral medication administration. This chapter provides an overview of the latest developments in the use of nanocarriers for oral medication delivery in the treatment of different disorders. The chapter also describes how diverse nanocarrier designs and technologies improve therapeutic potential by overcoming physical, biological, and biochemical obstacles. it is easy to produce, has few sterility limitations, is less expensive, has flexible dosage form design, and has high patient compliance, oral drug delivery (ODD) is the most convenient and favored method of drug administration. However, low medication bioavailability—which is influenced by three crucial factors—is one of the difficulties associated with oral drug delivery. The other is solubility. Many mathematical models that predict the medication's rate of solubility and dissolution have been developed in order to achieve efficient drug absorption in vivo. Similarly, models that are noncellular and cellular determine permeability. Furthermore, the medication's behavior in the gastrointestinal tract (GIT) is influenced by physiological parameters, such as pH, microbial colonization, and enzymes, as well as intrinsic drug properties. A drug's dosage form is a method of getting it into a living organism. The medicine must be administered to the site of action at a rate and concentration that will maximize therapeutic benefit and minimize side effects in order to provide the intended result. Although the oral method is still commonly used, swallowing tablets and capsules can be a regular problem. As a result, numerous studies on cutting-edge drug delivery methods have been conducted. This review focuses on oral dispersible tablets, a novel approach to drug delivery systems that are currently more focused on formulation and set a new course that not only helped patients increase their level of therapy compliance.